Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 287

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 287
---
 Warrants 
     -  
     1,131,771 
  
    Proceeds from Exercise of Pre-Funded Warrants 
     10,963  
     - 
  
    Proceeds from Notes Payable 
     -  
     650,000 
  
    Repayment of Notes Payable 
     -  
     (1,611,111)
  
    Proceeds from Advances - Related Party 
     -  
     250,000 
  
    Repayment of Related Party Advances 
     -  
     (250,000)
  
    Net Cash Provided by Financing Activities 
     7,053,571  
     6,474,565 

    Effect of Exchange Rate Changes on Cash 
     499  
     61,853 

    Change in Cash and Cash Equivalents 
     (483,132) 
     1,877,620 
  
    Cash and Cash Equivalents—Beginning of Period 
     2,142,485  
     264,865 
  
    Cash and Cash Equivalents—End of Period 
    $1,659,353  
    $2,142,485 

    SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION 

    Cash paid During the Year for Interest 
    $8,772  
    $179,117 
  
    Cash paid During the Year for Income Taxes 
    $2,000  
    $1,000 

    NONCASH INVESTING/FINANCING ACTIVITIES 

    Conversion of Debt into Common Stock 
    $-  
    $7,989,598 
  
    Conversion of Debt into Series A Preferred Stock 
    $-  
    $10,128,500 
  
    Conversion of Series A Preferred Stock into Common Stock 
    $290,601  
    $270,460 
  
    Capitalized Share-Based Payments to Vendors 
    $26,325  
    $4,916,555 
  
    Fair Value of Warrants Issued to Underwriters 
    $71,364  
    $301,416 
  
    Reclassification of Liability-classified Warrants to Equity-classified 
    $-  
    $838,748 
  
    Additions to ROU Assets for Lease Renewal 
    $-  
    $50,922